These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 27433094)
1. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma. Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094 [TBL] [Abstract][Full Text] [Related]
2. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
3. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study. Bi C; Liu M; Rong W; Wu F; Zhang Y; Lin S; Liu Y; Wu J; Wang L BMC Cancer; 2019 Mar; 19(1):213. PubMed ID: 30849962 [TBL] [Abstract][Full Text] [Related]
4. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis. Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420 [TBL] [Abstract][Full Text] [Related]
5. The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma. Tang L; Tan YX; Jiang BG; Pan YF; Li SX; Yang GZ; Wang M; Wang Q; Zhang J; Zhou WP; Dong LW; Wang HY Clin Cancer Res; 2013 Apr; 19(8):2014-24. PubMed ID: 23493353 [TBL] [Abstract][Full Text] [Related]
6. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma. Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis. Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094 [TBL] [Abstract][Full Text] [Related]
8. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma. Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137 [TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma. Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142 [TBL] [Abstract][Full Text] [Related]
10. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway. Zhao S; Wang J; Qin C J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741 [TBL] [Abstract][Full Text] [Related]
11. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance. Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920 [TBL] [Abstract][Full Text] [Related]
12. Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma. Bergeat D; Fautrel A; Turlin B; Merdrignac A; Rayar M; Boudjema K; Coulouarn C; Sulpice L J Surg Res; 2016 Jun; 203(2):441-50. PubMed ID: 27363654 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of neutrophil distribution in cholangiocarcinoma. Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010 [TBL] [Abstract][Full Text] [Related]
14. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma. Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486 [TBL] [Abstract][Full Text] [Related]
15. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma. He F; Yan Q; Fan L; Liu Y; Cui J; Wang J; Wang L; Wang Y; Wang Z; Guo Y; Huang G Hum Pathol; 2010 Mar; 41(3):415-24. PubMed ID: 19954816 [TBL] [Abstract][Full Text] [Related]
16. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma. Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642 [TBL] [Abstract][Full Text] [Related]
17. [Expression of melanoma antigen-1, 3 genes in human intrahepatic cholangiocarcinoma and its clinical significance]. Lu X; Zhao HT; Sang XT; Mao YL; Chen RR; Zhong SX; Huang JF Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Apr; 30(2):197-200. PubMed ID: 18505125 [TBL] [Abstract][Full Text] [Related]
18. IMP3 expression is associated with poor outcome and epigenetic deregulation in intrahepatic cholangiocarcinoma. Gao Y; Yang M; Jiang Z; Woda BA; Mercurio AM; Qin J; Huang X; Zhang F Hum Pathol; 2014 Jun; 45(6):1184-91. PubMed ID: 24745619 [TBL] [Abstract][Full Text] [Related]
19. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis. Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624 [TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma. Bunsiripaiboon P; Sornmayura P; Wilasrusmee C; Lertsithichai P J Med Assoc Thai; 2010 Jan; 93(1):66-72. PubMed ID: 20196413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]